J-Pharma

Public

J-Pharma is now publicly traded

The data on this page reflects J-Pharma's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Series F

Jul 7, 2025

Total Funding Raised

$73.89M

Company Overview

J-Pharma operates in Biotech and is based in Japan. It has raised $73.89M.

J-Pharma is a biotechnology company that specializes in the research and development of novel drugs targeting SLC transporters, particularly L-type amino acid transporter 1 (LAT1), for the treatment of cancer and autoimmune diseases.

Sector

Biotech

AI Layer

Non-AI

J-Pharma Comparables

Compare J-Pharma with similar companies based on industry and business-model similarity.

J-Pharma comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Otsuka Holdings	74%	Demo
Aetas Pharma Co., Ltd.	51%	Demo

Book a demo to see all comparables

For institutional investors. Book with your work email.

J-Pharma Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series F	Jul 7, 2025	Demo	Demo	Demo	Demo
Grant	Apr 1, 2025	Demo	Demo	Demo	Demo
Series E Extension	Apr 1, 2025	Demo	Demo	Demo	Demo
Series E	Oct 5, 2023	Demo	Demo	Demo	Demo
Series D	Jul 30, 2020	Demo	Demo	Demo	Demo

Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Yutaka Fujimoto

CFO

Executive Team

For institutional investors. Book with your work email.

J-Pharma Investors

Notable investors and investment history

J-Pharma investors
Investor	Rounds
Japan Agency for Medical Research and Development	Grant
QR Investment Co., Ltd.	Series E
Tokai Tokyo Investment Co., Ltd.	Series E Extension
F-Prime Capital	Series E
日本ベンチャーキャピタル株式会社	Series D
株式会社FFGベンチャービジネスパートナーズ	Series E Extension
JIC Venture Growth Investments	Series E Extension